Related Experiment Video
Updated: Jul 6, 2026
07:27
Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
Published on: January 23, 2026
A rare case of pulmonary emphysema
M Sotcan1, I Copaci, Mihaela Enache
13rd Internal Medicine Department, Central Military Hospital, Bucharest, Romania. sotcanm@yahoo.com
Summary
Alpha-1-antitrypsin deficiency (AAT) is a serious genetic disorder causing early-onset emphysema. This case highlights AAT deficiency complications like respiratory failure in a light smoker.
Area of Science:
- Pulmonology
- Genetics
- Internal Medicine
Background:
- Alpha-1-antitrypsin deficiency (AATD) is a prevalent lethal genetic disorder.
- It primarily manifests as early-onset panacinar emphysema, a severe form of COPD.
- Hepatic cirrhosis is a less common but serious complication.
Observation:
- A 40-year-old male, light smoker, presented with COPD and panacinar emphysema.
- His AAT levels were significantly low (72 mg/dl vs. normal 200-300 mg/dl).
- The patient developed cor pulmonale and chronic respiratory failure.
Findings:
- AAT deficiency is a primary cause of early-onset panacinar emphysema, often more severe at lung bases.
- Smoking exacerbates AATD, increasing emphysema severity and lowering age of onset.
- This case illustrates severe complications of AATD in a smoker.
Implications:
- Early diagnosis and management of AATD are crucial for preventing severe lung disease.
- Smoking cessation is vital for individuals with AATD to mitigate disease progression.
- Understanding AATD's impact on respiratory and hepatic health is key for comprehensive patient care.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...